Video LectureARCHIVED: NOT AVAILABLE FOR CREDIT
One of These Tests Is Not Like the Other: Comparative Effectiveness, Cost Effectiveness, and Utilization Guidance in Pain Management Testing

This lecture will focus on test utilization in the area of pain management testing. Clinical toxicology is one of the fastest growing areas of laboratory medicine, driven in large part by pain management needs. As a result, a wide variety of workflows have been implemented to address the needs of the patient, physician, and laboratory. Unfortunately, the complexity of test offerings, changing reimbursement strategies, and inherent marketplace competition have made test selection overly complex for the majority of providers.

This lecture will discuss why and how specific analytical methods are utilized and provide a deconvolution of several key concepts in toxicology. Important cost considerations from the point of view of the laboratory and provider will also be highlighted.

Originally posted on March 17, 2015 in Salt Lake City, Utah.



Lecture Presenter

Frederick G. Strathmann, PhD, DABCC (CC, TC)

Frederick G. Strathmann, PhD, DABCC (CC, TC)

Medical Director, Toxicology Laboratory
ARUP Laboratories
Associate Scientific Director, Mass Spectrometry
ARUP Laboratories
Assistant Professor of Pathology
University of Utah School of Medicine

Dr. Strathmann is a medical director of Toxicology and an associate scientific director of Mass Spectrometry at ARUP Laboratory, as well as an assistant professor of pathology at the University of Utah School of Medicine. Dr. Strathmann received his MS and PhD in pathology and laboratory medicine at the University of Rochester in New York, completed a clinical chemistry fellowship at the University of Washington in Seattle, and is ABCC board certified in clinical chemistry and toxicological chemistry.



Objectives

After this presentation, participants will be able to:

  • Discuss the various approaches to assay design to support pain management.
  • Compare and contrast several available strategies for determining pain management compliance testing.
  • Determine an optimized approach to testing for a typical pain management patient population.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories